6th International Conference on Brain Disorders and Therapeutics is on Jul 1 2019 at Paris

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme

Together Towards Enriching Brain Research

- Brain Disorders 2019

Report

We would like to thank all of our notable dignitaries for presenting us the wonderful keynotes, speakers, conference attendees, students, associations, media partners and guests for making Brain Disorder 2020 a successful and splendid event.

Allied Academies hosted the event of 7^thInternational Conference on Brain Disorders and Therapeutics during February 28-29, 2020 at Holiday Inn Rome Aurelia, Rome, Italy with the theme “Exploring the destiny of Brain Health” Benevolent response and active participation was received from the Editorial Board Members of supporting International Journals as well as from the leading academic scientists, researchers, research scholars, students and leaders from the fields of Neurology, Neuroscience ,Psychiatric and Brain Dynamic who made this event successful.

The conference was marked by the attendance of young and brilliant researchers, business delegates and talented student communities representing more countries, who have driven this event into the path of success. The conference highlighted through various sessions on Brain disorders research.

Brain Disorder 2020 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the fields of Brain Injury, Stroke, psychology and Brain Dynamic.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

Brain Disorders

Stroke
Neurodegenerative Disorders

Psychology

Neuro-opthamology

The conference proceedings were carried out through various Scientific-sessions and plenary lectures. The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk and testimonials received from the Keynote speakers and workshop were;

Caterina Guiot | University of Torino | Italy

Maria Joao Vieira | Centro Hospitalar Leiria | Portugal

Veronika Ketermina | Kuban State University | Russia

Nandita Chaube | Gujarat Forensic Sciences University | India

Elisabetta Ciani | University of Bologna | Italy

Rosari Naveena S | Gujarat Forensic Sciences University | India

Matthew Olaogun | Bowen University | Nigeria and Etc..,

The event enlightened various areas of Brain Disorders with Workshops and plenary lectures from the speakers of various universities and organizations like:

Birkbeck University of London | UK

First Moscow State Medical University | Russia

University of Stavanger | Norway

Gujarat Forensic Sciences University | India

Centro Hospitalar Leiria | Portugal

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Brain Disorders 2020.

With the grand success of Brain Disorder 2020, Allied Academies is proud to announce the "8th International Conference on Brain Disorders and Therapeutics” to be held during September 02-03, 2020 at Barcelona, Spain. For more information please visit: Brain Disorder 2020

Past Conference Report page: Click Here

To visit Brain Disorder Conference Book Proceedings: Will update shortly

Welcome Message

We exuberantly welcome and invite all delegates, speakers, exhibitors and sponsors from across the world to participate in the 6th International Conference on Brain Disorders and Therapeutics which is scheduled to be held from July 1-2, 2019 in Paris, France.

The conference has been placed along meticulously to fulfill the ennobling standards of our attendees and thus provides a felicitous forum that ensures interactive congregation of knowledge and intellect regarding the path-breaking researches on brain disorders being conducted across the world.

Our aim is to spur the progress of efforts to explain the untouched science behind the mystery of brain disorders, their mechanism, diagnosis, treatment and management inclusive of an active colloquy about the recent advances in the realm of brain disorders.

The conference will extend a platform for multidisciplinary exchange of information to battle brain disorders and shed light on the most sought after scientific discoveries in all its aspects. It will not only help you expand your horizon for associating with colleagues from across the world but it also comes with a well-designed program with sessions which impart the scope for discussion of cutting-edge researches in this field.

You would want to look forward to

ü Exceptional keynote speeches

ü Enlightening plenary lectures

ü Informatory poster and video presentations

ü Enriching workshops

ü Productive exhibitions

Who should attend

Neurologists, neurooncologists, psychiatrists, rehabilitation therapists, professors, doctors, research scholars and students. Business professionals and CEO’s and R&D Heads of industries are promised a very productive experience in expanding your network as well as resources. We welcome anyone who would like to make the best out of this amazing networking opportunity.

We would once again like to convey our heartiest welcome to the 6th International Conference on Brain Disorders and Therapeutics and eagerly look forward to seeing you in Paris!

Scientific Sessions

Sessionon: Brain and Brain Disorders

Brain isthe most complex and sensitive organ in the body. Minute damages to the brain might causedevastating consequences leading to several braindisorders. It may occur in early childhood causing developmentaldisorders such as autism and dyslexia .Psychiatric diseases such as depression and schizophrenia are typically diagnosed inteens or early adulthood and as we age we become increasinglysusceptible to Alzheimer’s disease, Parkinson’s disease, stroke, and other diseases.

This session encourages a discussion on the structural andfunctional aspects of the brainand the various dimensions of disease development.

RelatedConferences: 5^th International Conferenceon Brain Disorders andDementia Care | October 13-14, 2019 | Philadelphia, USA ; International Conference on Pain Management and Research| October 14-15, 2019 | Rome, Italy ; 19^th International Conferenceon Neurology and NeurologicalDisorders | November 4-5, 2019 | Melbourne Australia

Sessionon: Diagnosisof Brain Disorders

Early diagnosis of brain disorders iscrucial to determining the prognosis and treatment for the patient. Over thedecades, there has been immense advancements in the diagnostic tools andstrategies for various braindisorders. This session brings together researchers from around the worldand provides a platform for the discussion on newer strategies of early diagnosisof various brain disordersto ensure better survival rates of individuals.

Sessionon:Neurobiologyand Pathophysiology

ThePathophysiology of Brain disorders is influenced by multiplefactors such as Molecular and cell system, Altered cerebral hemodynamic,Cerebrovascular auto control, Cerebral oxygenation, Excitotoxic cell harm,Inflammation, Cerebral metabolic brokenness and Changes in coordination oradjust.

Sessionon: Neuroimmunologyof Brain

The objective of this session is to deliberateabout : Neuroimmunology, Neurovirology, Neuro-invulnerable pathology, Neuro-insusceptible Interaction, Neuropharmacology andTherapeutics, Neuropeptides and Neurohormones, Neurobiology of Brain Disorders andNeuro phonetics and Neuroheuristics.

Session on:Neuropharmacologyand Neurochemistry

Neurochemistry accomplishes theprocedures occurring in the sensory system and nerve tissues. One of thesemeasures is Neurotransmission, wherein, the communicationat the neurotransmitter occurs with the assistance of neurotransmitters, for example, Dopamine,Acetylcholine, Norepinephrine, Glutamate, Serotonin, Gamma-aminobutyriccorrosive (GABA), Endogenous opioids and so forth. Movement of particlechannels aids neurotransmitter receptors to get the signs. This system ischanged by the numerous medications, as a treatment procedure for neurological disorders.

The worldwideoffers of medications to treat dynamic dementia with other neurologicalvariations from the norm anticipated that would reach $537.2 million out of2012 and $913.7 million by 2017, at a CAGR of 11.2% over the five-year gaugeperiod.

Session on: NeurodegenerativeDisorders and Geriatrics

Brain disorders inthe form of neurodegenerativedisorders are prevalent in the geriatric population across the globeand have posed challenging problems both in the developed as well as developingcountries in terms of the medical services offered. Alzheimer’sdisease and Parkinson’sdisease are the most common brain disorders affectingthe geriatric population. In addition, these brain diseases are accompanied bya host of other disorders in the elderly. For instance, patients with Parkinson’sdisease are at a high risk of developing valvular heart disease. Thesession on neurodegenerative disorders and geriatrics is especially essentialto be included in the conference due to the rising problems of lack of properdisease management in the ever-increasing geriatric population globally.

Sessionon: Neurogenetics

Understandingthe genetics behind braindisorders is vital todetermining their pathophysiology and development; narrowing down to the mostefficient treatment options and building personalised treatment alternativesbased on the genetic makeup of the patient. Identification of causative genesfor brain disorders such as Parkinson’s disease and Alzheimer’s disease has exponentially expanded the possibilities of therapy bytargeting the causative genes and either inhibiting or overexpressing themdepending on the disease manifestation. This session is formulated to discussthe significance of genetics in brainresearch as well it provides aplatform to congregate diverse research attempts in the field ofneurogenetics.

Sessionon: Dementia

Dementia is not a particular illness. It represents aclass of symptoms which are linked to a decline in memory or other reasoningabilities sufficiently serious to diminish an individual’s ability to carry outdaily activities. Alzheimer’s disease accounts for 60-80 percent of dementia cases. Vascular dementia is the second most common type of dementia. However, there are numerous different conditionsthat can cause indications of dementia including some that are reversible, forexample, thyroid problems or nutrient inadequacies. The main cause of dementia is a damage to brain cells. Different types of dementia are linked to different regions in the brain.For example, hippocampus is the central region for learning and memory; and thesecells are often the first to be damaged. Therefore, loss of memory is one ofthe first signs of Alzheimer’s disease. While manifestations of dementia may largely differ among individuals, no lessthat two of the following symptoms must be fundamentally hindered to be viewedas dementia – memory, language and communication, capacityto pay attention and concentrate, thinking and judgement and perception ofvision.

Sessionon: Structuraland Functional Brain

The neural networkshows anatomical associations connecting an arrangement of neural componentsthough utilitarian availability is by and large gotten from time arrangementperceptions and portrays examples of measurable reliance among neural components.Cerebrum availability is in this way vital to illustrating how neurons and neural systemsprocess data. Cerebellum and brain stem are two of thethree primary parts of the human brain, the third onebeing cerebrum. Every one of these three sections of the cerebrum performs diversefunctions. This session encourages a discussion on the structural and functionalaspects of the brainand the various dimensions of disease development.

Sessionon: Neuroengineeringand Computational Brain

Computationalmodels are being applied to elucidate disruptions in the brain leading to brain disorders. This approach inculcates the fields of genomics, proteomicsand bioinformatics to identify the pathobiology and development of brain disorders. The computational models research strategy is appliedlargely to identify and validate biomarkers for specific neurological disorderswhich promise newer diagnostic and therapeutic alternatives. This sessionanticipates the congenial involvement of neurologists, bioinformatics,biomedical engineers to come together and discuss the potential applications ofcomputational neuroscience in addition to what is already known.

Sessionon: Neuro-oncologyand Brain Tumors

Theprimary focus of neuro-oncology research around the globe includes theidentification of risk factors which result in primary brain tumorigenesis and progression; identification and evaluation ofbiomarkers to diagnose brain malignancy along with elucidating the prognosis and response ofthe patients to therapy; development of new approaches that enhance the overallsurvival and ensure optimization of the patient’s quality of life. This sessionis of particular significance considering its interdisciplinary context whichdemands the expertise of neurosurgery, neuropathology, radiation oncology,medical oncology, neuroradioloogy and related fields. The session ensures asuccessful exchange of knowledge from the varied disciplines to betterunderstand and address the complications of brain tumors.

Session on: Neurosurgery

Neurosurgery being apractical procedure for treating brain disorders and injuries has seen profound, unending advances interms of the tools and technology used. These advances promise to enhance theaccuracy of diagnosis and intraoperative procedures. Neurosurgery has come along way from being regarded as one of the most complex procedures in themedical field to advances in simulation technology where neurosurgeons will beable to “rehearse” a surgical procedure or augment the actual surgery. Theconference opens the house for discussion on various aspects of neurosurgery and relatedfields through this session. Neurosurgeons from across the world can gather andbe enriched with the myriad of advancements taking place each second in thefield of neurosurgery.

Session on: BrainNursing

The objectiveof this session is to deliberate about nursing practices that can assist andplay an important role in the treatment of Brain Disorders. This sessionaims at discussion about: Advance Practice Nursing, Geriatric Nursing, MovementDisorders, Multiple Sclerosis, Neuro-Oncology,Neurotrauma, Pediatrics Nursing, Spine and Stroke.

Session on: PediatricNeurology

Pediatricneurology directs to a branch of medicine that revolves aroundthe diagnosis of neurological conditions in neonates (babies), newbornchildren, kids and teenagers. By and large, about 40-50% of the patients have epilepsy, while 20% have learning or developmental disabilities and20% suffer from headaches. The rest are treated for uncommon or rare conditions, forexample, metabolic or hereditary disorders. The opportunities open to bothclinical and basic researchers in this field are proceeding to expand.

Session on: Headachesand Migraine

Headaches can becategorised into primary headache, secondary headache and cranial neuralgias, facial pain and various headaches. Primary headaches incorporate cluster, migraine and tension headaches. Migraines are extreme, repeating, and agonizing headaches. They can be gone before or joined by sensory warning signsand other symptoms. According to a report by the American Migraine Association, they affect 36 million Americans, oraround 12% of the population.

Session on: Neurorehabilitation

Rehabilitation of an afflicted brain can nurture the reconnection of damaged neuralcircuits. The aim of rehabilitation involvessupporting the patient to revert to the highest degree of function andself-dependence. It also intends to enrich the individual’s quality of lifeemotionally, physically and socially by assisting them with daily activities,engaging them in speech therapy and in activities to improve muscle balance andcontrol. This session in our conference encourages rehabilitation groups,neurologists, counselors, psychiatrists and related experts to participate inthe discussion to formulate new rehabilitation approachesor revamp the existing ones to culminate into a faster and effective recovery.

Session on: NovelTherapeutic Strategies

Numerous therapeutics have emerged over the decades as scientists are progressivelymaking themselves acquainted with the complexity of neural networks. Muchrecent and innovative strategies include the application of nanotechnology toavert the onset of Alzheimer’s disease; using humanmonoclonal antibodies as a new approach to inhibit causative proteins andenzymes in brain disorders anddeveloping epigenetic therapeutics.Innovative therapeuticapproaches are key to developing safe and effective cure for brain disorders. Thissession indulges researchers in an interactive congregation to come up withnovel and precise therapeuticsfor brain disorders.

Session on: TechnologicalAdvances in Diagnosis and Treatment

The realm of neuroscience has witnessed the emergence of diverse innovative andhighly productive technologies in the last couple of years and will continue toexperience impressive innovations in the future. Brain-computerinterfaces are already assisting paralysed patients to carry outsimple tasks while deep-brainstimulators are relieving Parkinson’s disease patients fromthe tremors. Recent technological advances in diagnosis and treatment is anessential session of the conference which aims to bring together research anddevelopment carried out in this field from across the globe and share ideas toput forth the most efficient diagnostic and treatment strategies for brain disorders.

Related Conferences: 5^thInternational Conference on BrainDisorders and Dementia Care | October 13-14, 2019 | Philadelphia, USA ; International Conference on Pain Management and Research| October 14-15, 2019 | Rome, Italy ; 19^th International Conferenceon Neurology and NeurologicalDisorders | November 4-5, 2019 | Melbourne Australia

Sessionon: Animal Models in Brain Research

Animal models have beenused in all fields of medical research to study the progression of diseasesinside the organism. Brain researchers use animal models to analysevarious clinical conditions in animals which mimic that of humans and derivepotential therapeutic strategies for treatment. This session opens the houseto discussion about successful researches conducted on animal models and reasonsout the conflicts in application of these outcomes on the human brain.

Sessionon: Biofeedback and Neurofeedback

Neurofeedback is additionally called EEGbiofeedback, and it's especially valuablefor treating an assortment of neurological conditions. EEG input is normallyused to treat epilepsy, rest issue, nervousness, stress, ADHD and horrible brainwounds.

Session on: Case Reportsand Clinical Trials

CaseReports on brain disorders aim to conduct an evaluation of signs, symptoms, diagnosis, treatment, and follow-upof a patient for a brain disorder. Case reports are accounted as a proof of evidence for the patient in the clinicalfield. They assist vitally in the field of research for brain disorders. This session will focus on the ways toimprovise the current workflow of documenting case reports andperforming clinical trials.

Market Analysis

The global cost of brain and mental disorders was estimated to be $8.5 trillion in the year 2010. The cost of brain disorders and diseases in US alone is estimated at $1.5 trillion which is about eight percent of the gross domestic product. As of 2010, the total cost of brain disorders in Europe was €798 billion out of which 37% of the fund is spent on direct health care, 23% is non-medical cost while 40% is spent on all indirect expenditures.

Brain disorders cost higher than cardiovascular disease, cancer or diabetes. These disorders are predicted to be responsible for greater than half of the consummate economic burden from non-communicable diseases in the coming decades. Also keeping in mind that those suffering from brain disorders and mental illnesses are highly susceptible to cardiovascular diseases, respiratory diseases and diabetes, the cost for brain disorders and mental illnesses is reckoned to be even higher. According to 2010 reports, neurological disorders constituted 3 percent to the global burden of diseases and mental and behavioural disorders accounted for 7.4 percent. The leading neurological disorders namely migraine, epilepsy, Parkinson’s disease, dementias account for about 70 percent of the burden.

The top 10 countries involved in neuroscience research ranked according to their wealth of research are USA, UK, Germany, Japan, Canada, China, Italy, France, Australia, Spain.

Why France?

Neuroscience research in France is ranked third in Europe and seventh in the world. About 625 research teams are actively conducting research in the field of neurology, cognitive science, neuroscience and psychiatry at various institutions. Of the many projects funded by various organisations for research in healthcare and biology, a greater proportion is found in the field of neuroscience. French researchers are foremost in the field of neurosurgery and in the growth of brain-machine interfaces.

Why Paris?

The capital city is a hub for research in healthcare as much as it is the hub for fashion. Being an impressive blend of both worlds, Paris offers a great platform to host healthcare conferences owing to a large number of internationally acclaimed research institutes and universities. Its state-of-the-art laboratories covering all scientific disciplines makes Paris a very favourable destination for scientific meetings.

Past Conference Report

At the outset, we extend our heartfelt gratitude to the exceptional keynotes, speakers, conference attendees, media partners, associations, students and guests who made Brain Disorders 2018 a successful endeavour.

AAC hosted the 5^th International Conference on Brain Disorders and Therapeutics during November 5-6, 2018 at Holiday Inn Edinburgh which was set around the theme “Ensuring the Future of Brain Health”. Active and responsible participation of the Editorial Board Members of supporting International Journals as well as that of the preeminent academic researchers, professors, doctors and innovators in the field of Neurology focusing on Brain Disorders is entirely creditable for the success of this event.

The Brain Disorders Conference was marked by the presence of exceptionally knowledgeable researchers, business delegates and talented student communities representing 10+ countries driving this event to the path of success. It also witnessed a colloquy of speakers who edified the audience with their extensive knowledge of the various aspects of Brain Disorders like Brain Engineering, Neurology of Brain, Structural and Functional Brain etc

The proceedings of Brain Disorders 2018 were followed through with various scientific sessions and keynote forums. The conference commenced with an opening ceremony followed by a series of lectures delivered by our members of the keynote forum. Our adept attendees who uplifted the standard our event with their humble presence and extraordinary talks were;

Keynotes and Speakers at Brain Disorders 2018

Shinji Ohara | Matsumoto Medical Center | Japan

Robert G Harrington | University of Kansas | USA

Pamela K Douglas | University of Central Florida | USA

Gabriela Cristina de Paula | Federal University of Santa Catarina | Brazil

Thazhumpal Chacko Mathew | Kuwait University | Kuwait

Fahed Hakim | Technion- Israel Institute of Technology | Israel

Ishita Chatterjee | University of Calcutta | India

The following major scientific tracks set off significant discussions during the scientific sessions-

Brain Disorders

Neurology of Brain

Structural and Functional Brain

Brain Engineering

Neurodegenerative Disorders

Brain Complications

With the successful conclusion of Brain Disorders 2018, AAC is delighted to announce the 6^th International Conference on Brain Disorders and Therapeutics to be held during July 1-2, 2019 at Paris, France.